Glismart P 2mg/500mg/15mg Tablet ER
Marketer
LCB Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glismart P 2mg/500mg/15mg Tablet ER
Diabex Trio ER 2mg/500mg/15mg tablets combine medications to manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, this formulation enhances insulin effectiveness, reducing blood sugar. Always adhere to your physician's prescribed dosage and schedule; take with food to minimize stomach discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. Overdosing risks dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Inform your doctor of any kidney, liver, or heart conditions before use; pregnant or breastfeeding individuals require medical consultation. Kidney function tests are typically performed prior to commencing treatment. Limit alcohol consumption to reduce side effect potential.
Primary Ingredients of Glismart P 2mg/500mg/15mg Tablet ER
No text was provided to rewrite.
Uses of Glismart P 2mg/500mg/15mg Tablet ER
Managing Type 2 Diabetes
Major Benefits of Glismart P 2mg/500mg/15mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glismart P 2mg/500mg/15mg Extended-Release tablet whole; do not break, crush, or chew it. Administer this medication with food.
Common Side effects of Glismart P 2mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glismart P 2mg/500mg/15mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet; do not fracture, pulverize, or chew it. Consume Glismart P 2mg/500mg/15mg Extended-Release tablets with a meal.
How Glismart P 2mg/500mg/15mg Tablet ER works:
Glismart P ER tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their complementary actions improve blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further amplifies insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glismart P 2mg/500mg/15mg Extended-Release tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Glismart P tablets (2mg/500mg/15mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Glismart P tablets (2mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glismart P 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glismart P 2mg/500mg/15mg Extended-Release tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glismart P 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The use of Glismart P 2mg/500mg/15mg Extended-Release tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glismart P 2mg/500mg/15mg Tablet ER :
Should you forget a Glismart P 2mg/500mg/15mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glismart P 2mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently